Experimental studies show improved tendon-to-bone healing within 14 to 21 days, supported by enhanced fibroblast activity and increased angiogenesis that delivers oxygen and nutrients to injured tissue
What the Evidence Actually Supports Its worth being precise about the state of evidence, because the gap between preclinical research and proven human clinical outcomes is significant in this area: Strong preclinical evidence: Hundreds of cell culture and animal studies demonstrate GHK-Cus biological activity across multiple pathways Moderate clinical evidence for topical applications: Several controlled human trials support skin benefits of topical GHK-Cu formulations Limited human evidence for systemic effects: The more dramatic claims tissue regeneration, gene expression reset, anti-aging effects throughout the body are largely supported by in vitro and animal data without the controlled human trials required to confirm efficacy and safety The scientific communitys interest in GHK-Cu is well-founded
Individuals who may benet from Methylcobalamin injections include those with Vitamin B12 deciency, particularly if due to poor absorption associated with age, gastrointestinal disorders, or following certain surgeries
doi: 10.1016/j.ecoenv.2021.112947 150 YuanATStillmanMJ
10.1186/s13223-018-0280-7 111 SoaneR.FrierM.PerkinsA.JonesN.DavisS.IllumL
Sposb podawania: BPC-157 jest zazwyczaj podawane podskrnie, co oznacza, e jest wstrzykiwane pod skr za pomoc strzykawki insulinowej
